Friday, 12 April 2019

U.S. FDA approves Johnson & Johnson's bladder cancer drug

The U.S. Food and Drug Administration on Friday approved Johnson & Johnson's treatment for patients with a form of bladder cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)